Series C led by Pureos BioventuresFinancing to support completion of a Phase II trial of AntiBKV and to prepare manufacturing of drug for Phase IIISCHLIEREN / ZURICH, Switzerland (BUSINESS WIRE) Memo Therapeutics AG (“MTx”), a late-stage biotech company developing best-in-class therapeutic antibodies, announced to.
/PRNewswire/ The "Hemodynamic Monitoring Systems Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028: Segmented by Product.
Increasing prevalence of cardiovascular, COPD and respiratory diseases; development of next-generation non-invasive and minimally-invasive systems; and rapid growth in the surgical procedures are some of the key factors driving the global hemodynamic monitoring market.